Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11376 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1722 Views
-
Last post by NHE
-
- 0 Replies
- 1374 Views
-
Last post by NHE
-
- 4 Replies
- 1504 Views
-
Last post by NHE
-
- 0 Replies
- 1214 Views
-
Last post by NHE
-
- 0 Replies
- 1510 Views
-
Last post by NHE
-
- 0 Replies
- 1963 Views
-
Last post by frodo
-
- 0 Replies
- 2012 Views
-
Last post by NHE
-
- 0 Replies
- 1596 Views
-
Last post by NHE